Detalhe da pesquisa
1.
A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation.
J Hepatol
; 78(4): 783-793, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681160
2.
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy.
Ann Hematol
; 102(2): 323-328, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576532
3.
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia.
Br J Haematol
; 190(3): e169-e173, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32515072
4.
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL.
Curr Cancer Drug Targets
; 20(10): 811-817, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32598257
5.
[EGFR/HER1 inhibition: an example of new targeted therapies in non-small cell lung cancer]. / Neue molekulare Therapien beim nichtkleinzelligen Lungenkarzinom am Beispiel der EGFR/HER1-Inhibition.
Med Klin (Munich)
; 100(12): 785-93, 2005 Dec 15.
Artigo
em Alemão
| MEDLINE | ID: mdl-16453093
6.
Inclusion of targeted therapies in the standard of care for metastatic colorectal cancer patients in a German cancer center: the more the better?!
J Cancer Res Clin Oncol
; 141(3): 515-22, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25230900